Technical Analysis for PTN - Palatin Technologies, Inc.
|Grade||Last Price||% Change||Price Change|
PTN closed down 2.3 percent on Monday, December 11, 2017, on 68 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
|Weak or Absent||Up||Up||Down|
|See historical PTN trend table...|
|Date||Alert Name||Type||% Chg|
|Dec 11||NR7||Range Contraction||0.00%|
|Dec 11||Wide Bands||Range Expansion||0.00%|
|Dec 11||Oversold Stochastic||Weakness||0.00%|
|Dec 8||New Uptrend||Bullish||-2.30%|
|Dec 8||Wide Bands||Range Expansion||-2.30%|
|Dec 7||New Downtrend||Bearish||-0.58%|
|Dec 7||50 DMA Support||Bullish||-0.58%|
|Dec 7||Hammer Candlestick||Bullish||-0.58%|
|Dec 7||Lizard Bullish||Bullish Day Trade Setup||-0.58%|
|Dec 7||Non-ADX 1,2,3,4 Bullish||Bullish Swing Setup||-0.58%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Palatin Technologies, Inc., a biopharmaceutical company, engages in the development of peptide therapeutics for the treatment of diseases. Its drug development programs include Bremelanotide, a peptide melanocortin receptor agonist that is in Phase IIb clinical trials for the treatment of female sexual dysfunction; and PL-3994, a peptide mimetic natriuretic peptide receptor A agonist, which is in Phase I clinical trials for the treatment of cardiovascular and pulmonary indications, as well as melanocortin receptor-based compounds for treatment of obesity. The company was founded in 1986 and is based in Cranbury, New Jersey.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more PTN news...
|52 Week High||1.05|
|52 Week Low||0.2851|
|200-Day Moving Average||0.5168|
|50-Day Moving Average||0.8221|
|20-Day Moving Average||0.8937|
|10-Day Moving Average||0.9055|
|Average True Range||0.0579|
|Chandelier Exit (Long, 3 ATRs )||0.8763|
|Chandelier Exit (Short, 3 ATRs )||0.9237|
|Upper Bollinger Band||1.0272|
|Lower Bollinger Band||0.7602|
|Percent B (%b)||0.34|
|MACD Signal Line||0.039|
|Market Cap||152.18 Million|
|Num Shares||179 Million|
|Price-to-Earnings (P/E) Ratio||-10.63|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||0.90|
|Resistance 3 (R3)||0.91||0.89||0.89|
|Resistance 2 (R2)||0.89||0.88||0.89||0.89|
|Resistance 1 (R1)||0.87||0.87||0.86||0.87||0.89|
|Support 1 (S1)||0.84||0.85||0.83||0.83||0.81|
|Support 2 (S2)||0.82||0.84||0.82||0.81|
|Support 3 (S3)||0.80||0.82||0.81|
|Support 4 (S4)||0.80|